Virginia Retirement System’s Alexion Pharmaceuticals ALXN Stock Holding History

Virginia Retirement System’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$509K	Buy	+3,654	New	+$537K	0.01%	720

Other funds holding ALXN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Virginia Retirement System's ALXN Position: Q1 2016 in Review

Virginia Retirement System opened a new position in Alexion Pharmaceuticals (ALXN) in Q1 2016: 3,654 shares worth $509K. The stake represents 0.01% of the portfolio and ranks #720 among its holdings.

518 funds tracked by Wall St. Rank hold ALXN as of Q1 2016.

Virginia Retirement System held 3,654 shares of Alexion Pharmaceuticals worth $509K as of Q1 2016.
Alexion Pharmaceuticals was a new Virginia Retirement System position in Q1 2016.
Alexion Pharmaceuticals made up 0.01% of Virginia Retirement System's portfolio in Q1 2016, its #720 holding.
518 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q1 2016.

Based on Virginia Retirement System's 13F filing for Q1 2016, filed 29 Apr 2016.